{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:04:38Z","timestamp":1789646678320,"version":"4.0.0"},"reference-count":52,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2025Y9133"],"award-info":[{"award-number":["2025Y9133"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Selective glomerular hypofiltration syndrome (SGHS), defined by a low ratio of estimated glomerular filtration rate using cystatin C (eGFRcys) to estimated glomerular filtration rate using creatinine (eGFRcr), has emerged as a novel kidney dysfunction phenotype. Its role in diabetic kidney disease (DKD) remains unknown. This study aimed to investigate the association between SGHS and the prevalence of cardiovascular disease (CVD) at the time of renal biopsy-diagnosed DKD, as well as its association with long-term renal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>This study included 182 patients with biopsy-proven DKD. SGHS was defined as eGFRcys\/eGFRcr ratio &lt;0.60. Predictive value of the SGHS for the prevalence of CVD was assessed using receiver operating characteristic (ROC) curves. Independent risk factors for CVD prevalence were identified by logistic regression and used to construct a nomogram. ROC curves, calibration curves, decision curve analysis, and clinical impact curves were used for assessment of model performance. The impact of SGHS on renal outcomes was assessed using Kaplan-Meier curves and Cox regression. Subgroup analyses stratified by gender and body mass index categories were performed. Sensitivity analysis was conducted by redefining SGHS as eGFRcys\/eGFRcr ratio &lt;0.70.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 182 patients, 41 (22.5%) had SGHS. The eGFRcys\/eGFRcr ratio better predicted CVD (area under the curve (AUC) 0.730, 95% CI 0.643 to 0.816) than eGFRcr (AUC 0.602, 95% CI 0.507 to 0.697), eGFRcys (AUC 0.701, 95% CI 0.615 to 0.786), estimated glomerular filtration rate based on creatinine and cystatin C (AUC 0.685, 95% CI 0.595 to 0.774),\u2009and urinary albumin-to-creatinine ratio (AUC 0.633, 95% CI 0.540 to 0.725). SGHS was independently associated with CVD after adjustment (OR 9.27, 95% CI 3.20 to 26.84; p&lt;0.001). A nomogram incorporating SGHS demonstrated good discrimination (AUC 0.834; bias-corrected C-index 0.808) and calibration. Over a median follow-up of 30.1 months, patients with SGHS had higher cumulative DKD progression probability (log-rank test: \u03c7\u00b2=11.79, p&lt;0.001), and SGHS was an independent risk factor for DKD progression (HR 2.645, 95% CI 1.564 to 4.472; p&lt;0.001). Subgroup analyses and sensitivity analysis confirmed the robustness of these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SGHS is independently associated with the prevalence of CVD at the time of DKD diagnosis, and independently predicts adverse renal outcomes in patients with DKD. As an easily obtainable parameter, the eGFRcys\/eGFRcr ratio may serve as a valuable risk assessment tool in patients with DKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2026-006417","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:45:19Z","timestamp":1789645519000},"page":"e006417","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Selective glomerular hypofiltration syndrome: a novel renal phenotype associated with cardiovascular disease and adverse outcomes in diabetic kidney disease"],"prefix":"10.1136","volume":"14","author":[{"given":"Yuan","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Department of Nephrology, Zhongshan Hospital Xiamen University, Xiamen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuting","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4119-1715","authenticated-orcid":false,"given":"Xiaohong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6733-0472","authenticated-orcid":false,"given":"Jianxin","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091704450896000_14.5.e006417.1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"The Lancet"},{"key":"2026091704450896000_14.5.e006417.2","doi-asserted-by":"crossref","unstructured":"Hauwanga WN , Abdalhamed TY , Ezike LA , et al . The Pathophysiology and Vascular Complications of Diabetes in Chronic Kidney Disease: A Comprehensive Review. Cureus 2024;16. doi:10.7759\/cureus.76498","DOI":"10.7759\/cureus.76498"},{"key":"2026091704450896000_14.5.e006417.3","doi-asserted-by":"crossref","DOI":"10.5334\/gh.1460","article-title":"Optimising Access to Care for Patients with Heart and Kidney Diseases: A World Heart Federation and International Society of Nephrology White Paper","volume":"20","author":"Narula","year":"2025","journal-title":"Glob Heart"},{"key":"2026091704450896000_14.5.e006417.4","doi-asserted-by":"publisher","DOI":"10.3109\/00365513.2015.1025427"},{"key":"2026091704450896000_14.5.e006417.5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/joim.13589","article-title":"The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulation","volume":"293","author":"Malmgren","year":"2023","journal-title":"J Intern Med"},{"key":"2026091704450896000_14.5.e006417.6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/00365513.2015.1099724","article-title":"Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting","volume":"76","author":"Dardashti","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/00365513.2020.1759139","article-title":"Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities","volume":"80","author":"\u00c5kesson","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/00365513.2016.1223338","article-title":"The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study","volume":"76","author":"Christensson","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05320-w","article-title":"Impaired selective renal filtration captured by eGFRcysC\/eGFRcrea ratio is associated with mortality in a population based cohort of older women","volume":"12","author":"Malmgren","year":"2022","journal-title":"Sci Rep"},{"key":"2026091704450896000_14.5.e006417.10","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14939","article-title":"Potential relationship between eGFRcystatin C \/eGFRcreatinine -ratio and glomerular basement membrane thickness in diabetic kidney disease","volume":"9","author":"\u00d6berg","year":"2021","journal-title":"Physiol Rep"},{"key":"2026091704450896000_14.5.e006417.11","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12397","article-title":"Reduced glomerular size selectivity in late streptozotocin-induced diabetes in rats: application of a distributed two-pore model","volume":"3","author":"Lubbad","year":"2015","journal-title":"Physiol Rep"},{"key":"2026091704450896000_14.5.e006417.12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/1753-0407.12893","article-title":"Effect of diabetes mellitus on the recovery of changes in renal functions and glomerular permeability following reversible 24-hour unilateral ureteral obstruction","volume":"11","author":"Bakoush","year":"2019","journal-title":"J Diabetes"},{"key":"2026091704450896000_14.5.e006417.13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ekir.2018.09.002","article-title":"Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins","volume":"4","author":"Alm\u00e9n","year":"2019","journal-title":"Kidney Int Rep"},{"key":"2026091704450896000_14.5.e006417.14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/00365513.2021.1941235","article-title":"Mild impairment of renal function (shrunken pore syndrome) is associated with increased risk of a future first-ever myocardial infarction in women","volume":"81","author":"S\u00f6derstr\u00f6m","year":"2021","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.15","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1002\/ehf2.13485","article-title":"The Shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST-Malm\u00f6 study","volume":"8","author":"Xhakollari","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026091704450896000_14.5.e006417.16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00365513.2025.2585472","article-title":"Exploring the link between selective glomerular filtration and intima media thickness","volume":"85","author":"Lundbergs","year":"2025","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/gfad145","article-title":"Selective glomerular hypofiltration syndrome","volume":"39","author":"Quiroga","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026091704450896000_14.5.e006417.18","doi-asserted-by":"publisher","DOI":"10.1159\/000020698"},{"key":"2026091704450896000_14.5.e006417.19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010010010"},{"key":"2026091704450896000_14.5.e006417.20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1108"},{"key":"2026091704450896000_14.5.e006417.21","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S011"},{"key":"2026091704450896000_14.5.e006417.22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/eurheartj\/ehab853","article-title":"The \u2018Ten Commandments\u2019 of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"43","author":"Adamo","year":"2022","journal-title":"Eur Heart J"},{"key":"2026091704450896000_14.5.e006417.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001168"},{"key":"2026091704450896000_14.5.e006417.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"2026091704450896000_14.5.e006417.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy462"},{"key":"2026091704450896000_14.5.e006417.26","first-page":"1","article-title":"Cerebrovascular diseases: prevention, treatment, and rehabilitation. Report of a WHO meeting","volume":"469","year":"1971","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2026091704450896000_14.5.e006417.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"2026091704450896000_14.5.e006417.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2102953\/SUPPL_FILE\/NEJMOA2102953_DISCLOSURES.PDF"},{"key":"2026091704450896000_14.5.e006417.29","doi-asserted-by":"publisher","DOI":"10.1016\/J.KINT.2023.10.018"},{"key":"2026091704450896000_14.5.e006417.30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/00365513.2016.1149882","article-title":"Ratio of cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney function","volume":"76","author":"Purde","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.31","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf208","article-title":"Size-selective glomerular filtration as a hallmark of premature kidney ageing in nondiabetic individuals","volume":"18","author":"Laucyte-Cibulskiene","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026091704450896000_14.5.e006417.32","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf003","article-title":"Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis","volume":"18","author":"Liu","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026091704450896000_14.5.e006417.33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00125-025-06430-6","article-title":"The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II","volume":"68","author":"Bruce","year":"2025","journal-title":"Diabetologia"},{"key":"2026091704450896000_14.5.e006417.34","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-0821-9","article-title":"Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review","volume":"19","author":"Norris","year":"2018","journal-title":"BMC Nephrol"},{"key":"2026091704450896000_14.5.e006417.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-025-02852-z","article-title":"Diabetic kidney disease phenotypes and the risk of cardiovascular events: The Silesia Diabetes-Heart Project","volume":"24","author":"Janota-Sosi\u0144ska","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"2026091704450896000_14.5.e006417.36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.20233411S1852d","article-title":"Diabetic Kidney Disease Phenotypes and Cardiovascular Outcomes","volume":"34","author":"Claudel","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026091704450896000_14.5.e006417.37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1507\/endocrj.EJ14-0352","article-title":"Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes","volume":"62","author":"Ito","year":"2015","journal-title":"Endocr J"},{"key":"2026091704450896000_14.5.e006417.38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/00365513.2019.1576101","article-title":"The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C\/eGFRcreatinine-ratio","volume":"79","author":"Herou","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"key":"2026091704450896000_14.5.e006417.39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/00325481.2025.2580051","article-title":"Cardiovascular implications of glomerular filtration rate alterations beyond conventional chronic kidney disease classification","volume":"137","author":"Valtuille","year":"2025","journal-title":"Postgrad Med"},{"key":"2026091704450896000_14.5.e006417.40","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202000089","article-title":"Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations","volume":"15","author":"Xhakollari","year":"2021","journal-title":"Proteomics Clin Appl"},{"key":"2026091704450896000_14.5.e006417.41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ehf2.12623","article-title":"Association of soluble interleukin-2 receptor \u03b1 and tumour necrosis factor receptor 1 with heart failure: The Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Bakhshi","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026091704450896000_14.5.e006417.42","doi-asserted-by":"crossref","first-page":"155116","DOI":"10.1016\/j.jcrc.2025.155116","article-title":"Cystatin C-derived measures of renal function as risk factors for mortality and renal replacement therapy in the critically ill - An analysis of the SWECRIT cohort","volume":"89","author":"Linn\u00e9","year":"2025","journal-title":"J Crit Care"},{"key":"2026091704450896000_14.5.e006417.43","doi-asserted-by":"crossref","DOI":"10.3390\/nu18050721","article-title":"Selenoprotein P Deficiency Is Associated with Early Signs of Kidney Disease and Hospitalization Risk in Heart Failure","volume":"18","author":"Ohlsson","year":"2026","journal-title":"Nutrients"},{"key":"2026091704450896000_14.5.e006417.44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00330-023-09962-w","article-title":"Absolute and relative GFR and contrast medium dose\/GFR ratio: cornerstones when predicting the risk of acute kidney injury","volume":"34","author":"Nyman","year":"2024","journal-title":"Eur Radiol"},{"key":"2026091704450896000_14.5.e006417.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-025-04481-w","article-title":"Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients","volume":"26","author":"Ohlsson","year":"2025","journal-title":"BMC Nephrol"},{"key":"2026091704450896000_14.5.e006417.46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4093\/dmj.2011.35.6.602","article-title":"Serum cystatin C reflects the progress of albuminuria","volume":"35","author":"Yoo","year":"2011","journal-title":"Diabetes Metab J"},{"key":"2026091704450896000_14.5.e006417.47","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/dc24-2519","article-title":"Comparison of Serum Creatinine\u2013 and Cystatin C\u2013Based eGFR at Baseline and Their Prediction of Incident Moderate Albuminuria in Individuals With Type 1 Diabetes","volume":"48","author":"Harjutsalo","year":"2025","journal-title":"Diabetes Care"},{"key":"2026091704450896000_14.5.e006417.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05512-5"},{"key":"2026091704450896000_14.5.e006417.49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13300-023-01488-0","article-title":"Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study","volume":"15","author":"Otoda","year":"2024","journal-title":"Diabetes Ther"},{"key":"2026091704450896000_14.5.e006417.50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.897167","article-title":"SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R\/PI3K pathway","volume":"13","author":"Guo","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026091704450896000_14.5.e006417.51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4239\/wjd.v11.i12.596","article-title":"Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db\/db diabetic mice","volume":"11","author":"Klimontov","year":"2020","journal-title":"WJD"},{"key":"2026091704450896000_14.5.e006417.52","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1039\/D3FO03212D","article-title":"Association between adequate dietary protein and all-cause and cardiovascular mortality in patients with selective glomerular hypofiltration syndrome","volume":"15","author":"Shen","year":"2024","journal-title":"Food Funct"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2026-006417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:45:27Z","timestamp":1789645527000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2026-006417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,17]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjdrc-2026-006417"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2026-006417","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}